Ted W. Love
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.asserted
- Valid from
- 2024-02-01
- Valid until
- still holds
- Published
- 2024-02-02
- Recorded by AsOf
- 2026-11-12
- Checked
- 2026-11-12 · its source page states the value and the date
- Confidence
- 0.95
Sources
“On February 1, 2024, at a meeting of the Board of Directors (the “Board”) of Gilead Sciences, Inc. (the “Company”), the Board increased the size of the Board from nine directors to ten directors and elected Ted W. Love, M.D., to serve on the Board”— what the page says, read 2026-11-12
Cite this claim
Plain text
AsOf. "Gilead Sciences board member: Ted W. Love", as of 2024-02-01. Claim clm_2838DB8EBBD6, https://asof.is/claim/clm_2838DB8EBBD6, accessed 2026-11-12. Source: https://www.sec.gov/Archives/edgar/data/882095/000110465924010051/0001104659-24-010051-index.htm.
APA
AsOf. (2024). Gilead Sciences board member: Ted W. Love (as of 2024-02-01) [Record clm_2838DB8EBBD6]. Retrieved November 12, 2026, from https://asof.is/claim/clm_2838DB8EBBD6 (source: https://www.sec.gov/Archives/edgar/data/882095/000110465924010051/0001104659-24-010051-index.htm)
BibTeX
@misc{asof_clm_2838DB8EBBD6,
author = {AsOf},
title = {Gilead Sciences board member: Ted W. Love},
year = {2024},
howpublished = {\url{https://asof.is/claim/clm_2838DB8EBBD6}},
note = {Claim clm\_2838DB8EBBD6, as of 2024-02-01; source: https://www.sec.gov/Archives/edgar/data/882095/000110465924010051/0001104659-24-010051-index.htm},
urldate = {2026-11-12}
}On the record
/claim/clm_2838DB8EBBD6.md/v1/claims/clm_2838DB8EBBD6submit a correction